Systemic therapy augmented by radiotherapy (STAR) effect for brain metastases in a BRAF-mutated melanoma patient with prolonged survival: a case report

Brain metastases are common in stage IV malignant melanoma, carrying a prognosis traditionally regarded as severe, with a median survival of few months. Recently introduced systemic therapies as targeted therapy or immunotherapy have significantly improved the prognosis of metastatic melanoma. The o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cristaudo, Agostino, Malorgio, Antonio, Medoro, Serena, Stefanelli, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Radiation Oncology 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024180/
https://www.ncbi.nlm.nih.gov/pubmed/33794577
http://dx.doi.org/10.3857/roj.2020.00724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024180/
https://www.ncbi.nlm.nih.gov/pubmed/33794577
http://dx.doi.org/10.3857/roj.2020.00724

Ejemplares similares